72 related articles for article (PubMed ID: 32890460)
21. Tocotrienols Modulate a Life or Death Decision in Cancers.
Tham SY; Loh HS; Mai CW; Fu JY
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654580
[TBL] [Abstract][Full Text] [Related]
22. Targeting GDP-Dissociation Inhibitor Beta (GDI2) with a Benzo[
Sun Y; Zheng H; Qian L; Liu Y; Zhu D; Xu Z; Chang W; Xu J; Wang L; Sun B; Gu L; Yuan H; Lou H
JACS Au; 2023 Oct; 3(10):2749-2762. PubMed ID: 37885576
[TBL] [Abstract][Full Text] [Related]
23. The pyrazole derivative of usnic acid inhibits the proliferation of pancreatic cancer cells in vitro and in vivo.
Gimła M; Pyrczak-Felczykowska A; Malinowska M; Hać A; Narajczyk M; Bylińska I; Reekie TA; Herman-Antosiewicz A
Cancer Cell Int; 2023 Sep; 23(1):210. PubMed ID: 37743482
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance.
Chen JW; Chen S; Chen GQ
Cancer Drug Resist; 2023; 6(4):729-747. PubMed ID: 38239395
[TBL] [Abstract][Full Text] [Related]
25. Chronic diseases: Origin and cell mechanisms involved.
Martínez-Puente DH; Rodríguez-Roque CS; Flores-Zavala LM; Pérez-Trujillo JJ; Villanueva-Olivo A; Rodríguez-Rocha H; García-García A; Saucedo-Cárdenas O; Montes De Oca-Luna R; Loera-Arias MJ
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):26-37. PubMed ID: 38279502
[TBL] [Abstract][Full Text] [Related]
26. Trypsin-Instructed Self-Assembly on Endoplasmic Reticulum for Selectively Inhibiting Cancer Cells: Dedicated to Professor George M. Whitesides on the occasion of his 80th birthday.
Kim BJ; Fang Y; He H; Xu B
Adv Healthc Mater; 2021 Feb; 10(4):e2000416. PubMed ID: 32342647
[TBL] [Abstract][Full Text] [Related]
27. Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug.
Miller M; Mellul A; Braun M; Sherill-Rofe D; Cohen E; Shpilt Z; Unterman I; Braitbard O; Hochman J; Tshuva EY; Tabach Y
iScience; 2020 Jul; 23(7):101262. PubMed ID: 32585595
[TBL] [Abstract][Full Text] [Related]
28. Corrigendum: Paraptosis: a unique cell death mode for targeting cancer.
Hanson S; Dharan A; V JP; Pal S; Nair BG; Kar R; Mishra N
Front Pharmacol; 2023; 14():1274076. PubMed ID: 37745056
[TBL] [Abstract][Full Text] [Related]
29. Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction.
Li XQ; Ren J; Wang Y; Su JY; Zhu YM; Chen CG; Long WG; Jiang Q; Li J
Cell Oncol (Dordr); 2021 Feb; 44(1):135-150. PubMed ID: 32936421
[TBL] [Abstract][Full Text] [Related]
30. Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation.
Liu X; Gu Y; Bian Y; Cai D; Li Y; Zhao Y; Zhang Z; Xue M; Zhang L
Apoptosis; 2021 Apr; 26(3-4):195-208. PubMed ID: 33550458
[TBL] [Abstract][Full Text] [Related]
31. Programmed cell death in spinal cord injury pathogenesis and therapy.
Shi Z; Yuan S; Shi L; Li J; Ning G; Kong X; Feng S
Cell Prolif; 2021 Mar; 54(3):e12992. PubMed ID: 33506613
[TBL] [Abstract][Full Text] [Related]
32. Quercetin induces p53-independent cancer cell death through lysosome activation by the transcription factor EB and Reactive Oxygen Species-dependent ferroptosis.
Wang ZX; Ma J; Li XY; Wu Y; Shi H; Chen Y; Lu G; Shen HM; Lu GD; Zhou J
Br J Pharmacol; 2021 Mar; 178(5):1133-1148. PubMed ID: 33347603
[TBL] [Abstract][Full Text] [Related]
33. Proteasomal dysfunction and ER stress triggers 2'-hydroxy-retrochalcone-induced paraptosis in cancer cells.
Nedungadi D; Binoy A; Pandurangan N; Nair BG; Mishra N
Cell Biol Int; 2021 Jan; 45(1):164-176. PubMed ID: 33049087
[TBL] [Abstract][Full Text] [Related]
34. Emerging role of immunogenic cell death in cancer immunotherapy.
Arimoto KI; Miyauchi S; Liu M; Zhang DE
Front Immunol; 2024; 15():1390263. PubMed ID: 38799433
[TBL] [Abstract][Full Text] [Related]
35. Independent organelle and organelle-organelle interactions: essential mechanisms for malignant gynecological cancer cell survival.
Shen Y; Chen QC; Li CY; Han FJ
Front Immunol; 2024; 15():1393852. PubMed ID: 38711526
[TBL] [Abstract][Full Text] [Related]
36. Ezetimibe Induces Paraptosis through Niemann-Pick C1-like 1 Inhibition of Mammalian-Target-of-Rapamycin Signaling in Hepatocellular Carcinoma Cells.
Yin Y; Wu C; Zhou Y; Zhang M; Mai S; Chen M; Wang HY
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38275586
[TBL] [Abstract][Full Text] [Related]
37. Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy.
Yan T; Ma X; Guo L; Lu R
Cancer Biol Med; 2023 Oct; 20(10):748-64. PubMed ID: 37817482
[TBL] [Abstract][Full Text] [Related]
38. Paraptosis: a non-classical paradigm of cell death for cancer therapy.
Xu CC; Lin YF; Huang MY; Zhang XL; Wang P; Huang MQ; Lu JJ
Acta Pharmacol Sin; 2024 Feb; 45(2):223-237. PubMed ID: 37715003
[TBL] [Abstract][Full Text] [Related]
39. CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.
Zhao N; Wang C; Guo P; Hou J; Yang H; Lan T; Zhou Y; Li J; Bhawal UK; Liu Y
Bioengineered; 2022 Apr; 13(4):10956-10972. PubMed ID: 35484984
[TBL] [Abstract][Full Text] [Related]
40. Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein.
Li GM; Chen JR; Zhang HQ; Cao XY; Sun C; Peng F; Yin YP; Lin Z; Yu L; Chen Y; Tang YL; Xie XF; Peng C
Evid Based Complement Alternat Med; 2021; 2021():4582412. PubMed ID: 34457021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
